Global Bridges, established in collaboration with Mayo Clinic and the American Cancer Society, is an international network of healthcare professionals and organizations dedicated to advancing evidence-based tobacco dependence treatment and effective tobacco control policy. Since its inception in 2010, Global Bridges partners and grantees have created culturally-relevant training curricula based on established best practice and trained more than 20.000 healthcare professionals from 62 countries.
Our multilingual website, globalbridges.org helps facilitate collaboration worldwide. Global Bridges, in partnership with Pfizer Independent Grants for Learning and Change, is working with European organisations to make a difference to healthcare providers and their patients who want to stop using tobacco.
The Campaign for Tobacco-Free Kids works with non-governmental organizations and governments to pass and implement the policies proven to reduce tobacco use. We provide legal, media, and research support in the United States and around the world to assist in promoting, adopting and implementing tobacco control policies. The Campaign also provides grants to governments and non-governmental organizations in low- and middle-income countries to accelerate progress in tobacco control.
We are proud to work as a partner in the Bloomberg Initiative to Reduce Tobacco Use and with funding from the Bill & Melinda Gates Foundation.
The Campaign actively supports the Framework Convention on Tobacco Control. We are a founding member of the Framework Convention Alliance, a coalition of nearly 500 organizations from more than 100 countries that was formed to support FCTC negotiations and ensure the treaty’s proper implementation.
Tobacco Prevention & Cessation, (Abbr: Tob. Prev. Cessation; ISSN:2459-3087) is an open access, peer-reviewed online journal that encompasses all aspects of tobacco use, prevention and cessation that can promote a tobacco free society. The aim of the journal is to foster, promote and disseminate research involving tobacco use, prevention, policy implementation at a regional, national or international level, disease development- progression related to tobacco use, tobacco use impact from the cellular to the international level and finally the treatment of tobacco attributable disease through smoking cessation.
Tobacco Induced Diseases encompasses all aspects of tobacco induced diseases and their prevention. The journal aims to further the development of the scientific basis for the biological effects of tobacco smoke and its active components and to describe the distribution of tobacco diseases throughout the world.
The journal encourages the submission of articles from all medical, biological and psychosocial disciplines, ranging from medical and dental clinicians, through nurses and health professionals to basic biomedical scientists.
Tobacco Induced Diseases is the official journal of the International Society for the Prevention of Tobacco Induced Diseases.
The European Cancer Patient Coalition (ECPC) is the largest European patients’ umbrella organization in the area of cancer diseases, and is based in Brussels. ECPC was set up in 2003, and works for a Europe of equality, where all European cancer patients have timely and affordable access to the best treatment and care available, throughout their life.
Unfaintobacco.org, a project run by BLUE 21 e.V. in Berlin, Germany, is dedicated to raise awareness of the devastating impact of tobacco growing and tobacco use on sustainable development. Since 2004, Unfairtobacco.org is offering expertise in particular aspects of trade, human rights, and environment occuring in the tobacco sector. Futhermore, it is providing educational material for schools, organising public events, and working with policital decision makers at national and international level.
Unfairtobacco.org receives funding from the Federal Ministry for Economic Cooperation and Development (BMZ). We are a member of the Framework Convention Alliance, actively supporting the implementation of the Framework Convention on Tobacco Control, and of the Health and Trade Network, working for trade agreements, that truly safeguard the right to health.
The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) is an independent non-profit organisation with its central office located in Brussels, Belgium. EFA is a European alliance of 35 allergy, asthma and chronic obstructive pulmonary disease (COPD) patients’ associations representing 30% of European citizens currently living with these diseases.
EFA is member of various organisations, including European Patients’ Forum (EPF), Health and Environment Alliance (HEAL), European Network for Tobacco Control & Smoking Prevention (ENSP), Global Allergy and Asthma Patient’s Platform (GAAP) or WHO Global Alliance Against Respiratory Diseases (GARD), and partners with healthcare professionals and other health non-profit organisations.